The effect of heterogeneity on optimal regimens in cancer chemotherapy

Mathematical Biosciences

Volumn 185, Issue 1, 2003, Pages 73-87

  Murray, J M ^a   Coldman, A J ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Cancer chemotherapy; Heterogeneity; Optimal regimen

Indexed keywords

DRUG INTERACTIONS; MATHEMATICAL MODELS; ONCOLOGY; TUMORS;

HETEROGENEITY ANALYSIS;

CHEMOTHERAPY;

CANCER; DRUG PRESCRIBING; MEDICINE;

ARTICLE; CALCULATION; CANCER CHEMOTHERAPY; DRUG RESEARCH; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PARAMETER; TREATMENT OUTCOME;

EID: 0041826833     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(03)00093-2     Document Type: Article

References (25)

1. V.T. Devita, Principles of chemotherapy, in: V.T. Devita, S. Hellman, S.A. Rosenberg (Eds.), Principles and Practice of Oncology, 3rd Ed., Lippincott, Philadelphia, PA, 1989, p. 278.
2. I.J. Fidler, Cancer metastasis, Brit. Med. Bull. 47 (1991) 157.
3. T.C. Hall, Cancer Drug Resistance, Progress in Clinical and Biological Research, vol. 223, Alan Liss, New York, 1986.
4. B.T. Hill, Biochemical and cell kinetic aspects of drug resistance, in: N. Bruchovsky, J.H. Goldie (Eds.), Drug and Hormone Resistance in Neoplasia, vol. 1, CRC, Boca Raton, FL, 1983, p. 21.
5. V. Ling, Genetic basis of drug resistance in mammalian cells, in: N. Bruchovsky, J.H. Goldie (Eds.), Drug and Hormone Resistance in Neoplasia, vol. 1, CRC, Boca Raton, FL, 1983, p. 1.
6. S.E. Luria, M. Delbruck, Mutations of bacteria from virus sensitivity to virus resistance, Genetics 28 (1943) 491.
7. A. Coldman, J.H. Goldie, A model for the resistance of tumor cells to cancer chemotherapeutic agents, Math. Biosci. 65 (1983) 291.
8. R.S. Day, Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy, Cancer Res. 46 (1986) 3876.
9. L.E. Harnevo, Z. Agur, Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency, Can. Chemo. Pharm. 30 (1992) 469.
10. R.B. Martin, M.E. Fisher, R.F. Minchin, K.L Teo, Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells, Math. Biosci. 110 (1992) 221.
11. J.H. Goldie, A.J. Coldman, Drug Resistance in Cancer, Cambridge University, Cambridge, 1998, p. 9.
12. L. Norton, R. Simon, Tumor size, sensitivity to therapy, and design of treatment schedules, Can. Treat. Rep. 61 (1977) 1307.
13. J. Cairns, J. Overbaugh, S. Miller, The origin of mutants, Nature 335 (1988) 142.
14. H.E. Skipper, F.M. Schabel Jr., W.S. Wilcox, Experimental evaluation of anticancer agents. XIII. On the criteria and kinetics associated with curability of experimental leukemia, Cancer Chemoth. Rep. 35 (1964) 1.
15. P. Rubin, Statement of the clinical oncologic problem, in: P. Rubin, R.F. Bakemeier, S.K. Krackov (Eds.), Clinical Oncology a Multi-disciplinary Approach, 6th Ed., American Cancer Society, 1983, p. 8.
16. D. Hochhauser, A.L. Harris, Drug resistance, Brit. Med. Bull. 47 (1991) 178.
17. P. Valagussa, G. Bonnadonna, U. Veronesi, Patterns of relapse and survival in operable breast carcinoma with positive and negative axillary nodes, Tumori 64 (1978) 241.
18. H.E. Skipper, Repopulation rates of Breast Cancer Cells after Mastectomy (booklet #2), Southern Research Institute, Birmingham, AL, USA, 1979.
19. I.J. Fidler, M.L. Kripke, Metastasis results from pre-existing variant cells within a malignant tumour, Science 197 (1977) 893.
20. E. Galante, A. Guzzon, G. Gallus, M. Mauri, A. Bono, A. de Carli, M. Merson, S. Di Pietro, Prognostic significance of the growth rate of breast cancer: preliminary evaluation on the follow-up of 196 breast cancers, Tumori 67 (1981) 333.
21. A.J. Coldman, J.M. Murray, Optimal control for a stochastic model of cancer chemotherapy, Math. Biosci. 162 (2000) 187.
22. T.S. Ferguson, Mathematical Statistics: A Decision Theoretic Approach, Academic Press, New York, 1967, p. 102.
23. E. Chu, V.T. DeVita Jr., Principles of cancer management, in: Cancer: Principles and Practice of Oncology, 6th Ed., Lippincott, Williams and Wilkins, Philadelphia, PA, 2001, p. 289.
24. A.K. Laird, S.A. Tyler, A.D. Barton, Dynamics of normal growth, Growth 29 (1965) 233.
25. D.J. Finny, The median lethal dose and its estimation, Arch. Toxicol. 56 (1985) 215.